Skip to main content

Values First Advisors, Inc.

SEC CIK
0001913608
Latest filing
Aug 4, 2026

COLL holding history

Collegium Pharmaceutical, Inc in every 13F filed by Values First Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

COLL overviewAll 13F holders of COLLFull Q2 2026 holdings

Shares (Q2 2026)
18,013
Value
$652.1K
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of COLL by Values First Advisors, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,013$652.1K0.3%+927+5.4%AddedHolders
Q1 202617,086$565.0K0.3%+83+0.5%AddedHolders
Q4 202517,003$787.2K0.4%−582−3.3%ReducedHolders
Q3 202517,585$615.3K0.3%−864−4.7%ReducedHolders
Q2 202518,449$545.5K0.3%+1,804+10.8%AddedHolders
Q1 202516,645$496.5K0.3%−261−1.5%ReducedHolders
Q4 202416,906$484.3K0.3%−1,506−8.2%ReducedHolders
Q3 202418,412$711.4K0.4%+1,419+8.4%AddedHolders
Q2 202416,993$547.2K0.3%+1,057+6.6%AddedHolders
Q1 202415,936$618.6K0.4%−17,929−52.9%ReducedHolders
Q4 202333,865$1.04M0.6%−9,642−22.2%ReducedHolders
Q3 202343,507$972.4K0.6%+6,557+17.7%AddedHolders
Q2 202336,950$794.1K0.5%+7,325+24.7%AddedHolders
Q1 202329,625$710.7K0.5%−18,003−37.8%ReducedHolders
Q4 202247,628$1.10M0.8%+2,193+4.8%AddedHolders
Q3 202245,435$728.0K0.5%−2,652−5.5%ReducedHolders
Q2 202248,087$852.0K0.6%+2,474+5.4%AddedHolders
Q1 202245,613$929.0K0.6%+3,301+7.8%AddedHolders
Q4 202142,312$790.0K0.5%+539+1.3%AddedHolders
Q3 202141,773$825.0K0.5%+4,551+12.2%AddedHolders
Q2 202137,222$880.0K0.6%+4,325+13.1%AddedHolders
Q1 202132,897$780.0K0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.